Peer to Peer Mentoring: Facilitating Individuals With Early Inflammatory Arthritis to Manage Their Arthritis: Peer Mentoring Program

This study has been completed.
Sponsor:
Collaborator:
Canadian Arthritis Network
Information provided by (Responsible Party):
Dr. Mary Bell, Sunnybrook Health Sciences Centre
ClinicalTrials.gov Identifier:
NCT01054131
First received: January 21, 2010
Last updated: December 23, 2011
Last verified: December 2011
  Purpose

Inflammatory arthritis (IA) is a major cause of long-term disability. Peer support may be a solution to the common problem of delayed treatment. Early peer support may result in improved use of therapy, higher self-efficacy, reduced anxiety, and improved coping in the first two years post-diagnosis. The whole intervention study comprises of two parts: The first part involves the development and testing of a peer mentor training initiative, which is called "Peer to Peer Mentoring: Facilitating Individuals with Early Inflammatory Arthritis to Manage their Arthritis - Peer Mentor Training". The second part, which is the focus of this study, involves the delivery of a one-on-one peer support intervention from a trained peer mentor to an individual newly diagnosed with EIA. The feasibility and acceptability of the program will be determined, as well as the health outcomes following the participation of the program.


Condition Intervention
Early Inflammatory Arthritis
Chronic Disease
Behavioral: peer support

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Primary Purpose: Supportive Care
Official Title: Peer to Peer Mentoring: Facilitating Individuals With Early Inflammatory Arthritis to Manage Their Arthritis: Peer Mentoring Program

Resource links provided by NLM:


Further study details as provided by Sunnybrook Health Sciences Centre:

Primary Outcome Measures:
  • DMARD adherence [ Time Frame: 0, 3, 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • coping efficacy [ Time Frame: 0, 3 6 months ] [ Designated as safety issue: No ]
  • self-management [ Time Frame: 0, 3, 6 months ] [ Designated as safety issue: No ]
  • anxiety [ Time Frame: 0, 3, 6 months ] [ Designated as safety issue: No ]
  • self efficacy [ Time Frame: 0, 3, 6 months ] [ Designated as safety issue: No ]
  • social support [ Time Frame: 0, 3, 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 10
Study Start Date: January 2010
Study Completion Date: December 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: peer support
    A quasi-experimental, before and after study design will obtain data for planning and implementing a larger-scale study. Exposures and outcomes will be measured at baseline, 3 months (immediate post 12-week program) and 6 months (3 months post-program). Ten individuals with EIA will be recruited by brief screening interviews to ensure they meet inclusion criteria. Each pair of peer mentor and EIA participant will meet at SHSC for an initial contact. EIA participants will receive informational, emotional and appraisal support from trained peer mentors by telephone or neutral private location at a time convenient for both parties, at least once a week for 12 weeks.
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Have EIA disease duration within 6-52 weeks
  2. At least 3 swollen joints, assessed by the treating rheumatologist, OR positive compression test for the metacarpophalangeal joints OR positive compression test for the metatarsophalangeal joints OR at least 30 minutes of morning stiffness
  3. Prescription of a DMARD/biologic by the treating rheumatologist
  4. Ability to speak and understand English without the aid of a secondary support person; AND
  5. Capability to provide informed consent.

Exclusion Criteria:

  1. IA disease duration less than 6 weeks or greater than 1 year
  2. Previous or ongoing DMARD or biologic treatment
  3. Inability to speak or read grade 6 English; AND
  4. Inability to provide informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01054131

Locations
Canada, Ontario
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Sponsors and Collaborators
Sunnybrook Health Sciences Centre
Canadian Arthritis Network
Investigators
Principal Investigator: Mary J Bell, MD, FRCPC Rheumatologist, Sunnybrook Health Sciences Centre
  More Information

No publications provided

Responsible Party: Dr. Mary Bell, Rheumatologist, Sunnybrook Health Sciences Centre
ClinicalTrials.gov Identifier: NCT01054131     History of Changes
Other Study ID Numbers: 420-2009
Study First Received: January 21, 2010
Last Updated: December 23, 2011
Health Authority: Canada: Ethics Review Committee

Keywords provided by Sunnybrook Health Sciences Centre:
peer support
peer mentor
self-management
early inflammatory arthritis
chronic disease

Additional relevant MeSH terms:
Arthritis
Chronic Disease
Joint Diseases
Musculoskeletal Diseases
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on April 15, 2014